Episode Details
Back to Episodes
Pharmaceutical Executive Daily: September 18, 2025
Published 8 months ago
Description
In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock Bio’s $50 million Series A funding to advance its lead molecule, and FDA warning letters issued to Novo Nordisk, Eli Lilly, and Hims over misleading drug advertising.